Payment overview · 2025
General Payments
$121.21
6 reported records · 6 companies
Healthcare provider profile · identity verified
David Parnell Hill, DO
Allopathic & Osteopathic Physicians|Family Medicine · CUERO, TX · NPI 1447228135
Verified facts
What the public records show
CMS Open Payments records show David Parnell Hill, DO received $121.21 in general payments during 2025 across 6 reported records.
VERTEX PHARMACEUTICALS INCORPORATED accounted for 24.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Unresolved — no canonical attribution shown | $29.73 | 24.5% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $23.56 | 19.4% | 1 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $20.00 | 16.5% | 1 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $18.01 | 14.9% | 1 | 2025 |
| Solventum Corporation | Unresolved — no canonical attribution shown | $16.12 | 13.3% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $13.79 | 11.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $101.21 | 5 |
| Education | $20.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| JOURNAVX Normalized: journavx |
Drug | VERTEX PHARMACEUTICALS INCORPORATED | $29.73 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $23.56 | 1 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.01 | 1 | 2025 |
Source payment records
|
|||||
| ACTIV.A.C. Normalized: activ a c |
Device | Solventum Corporation | $16.12 | 1 | 2025 |
Source payment records
|
|||||
| PREVENA Normalized: prevena |
Device | Solventum Corporation | $16.12 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $13.79 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 565 | 87 |
| Lisinopril | Lisinopril | 474 | 121 |
| Losartan Potassium | Losartan Potassium | 453 | 118 |
| Alprazolam | Alprazolam | 406 | 76 |
| Atorvastatin Calcium | Atorvastatin Calcium | 396 | 112 |
| Amlodipine Besylate | Amlodipine Besylate | 373 | 102 |
| Gabapentin | Gabapentin | 356 | 94 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 321 | 90 |
| Levothyroxine Sodium | Levothyroxine Sodium | 296 | 80 |
| Pantoprazole Sodium | Pantoprazole Sodium | 278 | 76 |
| Tamsulosin Hcl | Tamsulosin Hcl | 243 | 71 |
| Metoprolol Succinate | Metoprolol Succinate | 240 | 73 |
| Metformin Hcl | Metformin Hcl | 236 | 71 |
| Metoprolol Tartrate | Metoprolol Tartrate | 198 | 46 |
| Furosemide | Furosemide | 196 | 64 |
| Hydrochlorothiazide | Hydrochlorothiazide | 189 | 53 |
| Omeprazole | Omeprazole | 181 | 43 |
| Pravastatin Sodium | Pravastatin Sodium | 176 | 49 |
| Tramadol Hcl | Tramadol Hcl | 171 | 42 |
| Zolpidem Tartrate | Zolpidem Tartrate | 171 | 37 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 170 | 60 |
| Potassium Chloride | Potassium Chloride | 168 | 53 |
| Celecoxib | Celecoxib | 135 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 135 | 41 |
| Glipizide Er | Glipizide | 123 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 122 | 27 |
| Allopurinol | Allopurinol | 120 | 36 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 120 | 34 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 116 | 31 |
| Metformin Hcl Er | Metformin Hcl | 116 | 30 |
| Simvastatin | Simvastatin | 115 | 29 |
| Montelukast Sodium | Montelukast Sodium | 108 | 32 |
| Oxycodone Hcl | Oxycodone Hcl | 103 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 102 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 100 | 27 |
| Pregabalin | Pregabalin | 99 | 37 |
| Amitriptyline Hcl | Amitriptyline Hcl | 93 | 21 |
| Famotidine | Famotidine | 93 | 27 |
| Meloxicam | Meloxicam | 86 | 31 |
| Sertraline Hcl | Sertraline Hcl | 81 | 29 |
| Trazodone Hcl | Trazodone Hcl | 80 | 23 |
| Glipizide | Glipizide | 77 | 24 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 77 | 21 |
| Donepezil Hcl | Donepezil Hcl | 74 | 18 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 74 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 71 | 21 |
| Eliquis | Apixaban | 69 | 18 |
| Diclofenac Sodium | Diclofenac Sodium | 68 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 67 | 24 |
| Eszopiclone | Eszopiclone | 66 | 13 |
| Baclofen | Baclofen | 65 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 65 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 65 | 19 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 62 | 14 |
| Alendronate Sodium | Alendronate Sodium | 60 | 17 |
| Finasteride | Finasteride | 58 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 55 | suppressed |
| Azithromycin | Azithromycin | 54 | 48 |
| Methylprednisolone | Methylprednisolone | 54 | 51 |
| Ondansetron Odt | Ondansetron | 53 | 23 |
| Hydralazine Hcl | Hydralazine Hcl | 52 | 11 |
| Jardiance | Empagliflozin | 51 | 12 |
| Trulicity | Dulaglutide | 51 | suppressed |
| Clonazepam | Clonazepam | 49 | 12 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 47 | suppressed |
| Carvedilol | Carvedilol | 45 | 13 |
| Prednisone | Prednisone | 45 | 19 |
| Spironolactone | Spironolactone | 45 | 12 |
| Clonidine Hcl | Clonidine Hcl | 43 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 42 | 13 |
| Mupirocin | Mupirocin | 42 | 31 |
| Ropinirole Hcl | Ropinirole Hcl | 42 | 11 |
| Doxazosin Mesylate | Doxazosin Mesylate | 41 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 40 | 12 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 39 | suppressed |
| Ibuprofen | Ibuprofen | 39 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 39 | 11 |
| Lorazepam | Lorazepam | 38 | 12 |
| Morphine Sulfate Er | Morphine Sulfate | 38 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 37 | 16 |
| Irbesartan | Irbesartan | 36 | suppressed |
| Ezetimibe | Ezetimibe | 35 | 11 |
| Nitroglycerin | Nitroglycerin | 35 | 20 |
| Ozempic | Semaglutide | 35 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 35 | suppressed |
| Atenolol | Atenolol | 34 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 26 |
| Bupropion Xl | Bupropion Hcl | 33 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 27 |
| Cephalexin | Cephalexin | 32 | 22 |
| Nifedipine Er | Nifedipine | 32 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 32 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 31 | suppressed |
| Linzess | Linaclotide | 31 | suppressed |
| Mirtazapine | Mirtazapine | 31 | 12 |
| Lamotrigine | Lamotrigine | 30 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Methocarbamol | Methocarbamol | 29 | suppressed |
| Movantik | Naloxegol Oxalate | 29 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 29 | 13 |
| Terbinafine Hcl | Terbinafine Hcl | 29 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 28 | suppressed |
| Lovastatin | Lovastatin | 28 | suppressed |
| Tradjenta | Linagliptin | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | 12 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 27 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 27 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 19 |
| Fentanyl | Fentanyl | 26 | suppressed |
| Novolog Flexpen | Insulin Aspart | 26 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 25 | suppressed |
| Nystatin | Nystatin | 25 | 15 |
| Testosterone Cypionate | Testosterone Cypionate | 25 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 24 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 24 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 23 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 23 | suppressed |
| Calcitriol | Calcitriol | 22 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Mounjaro | Tirzepatide | 22 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 22 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 11 |
| Glyxambi | Empagliflozin/Linagliptin | 21 | suppressed |
| Memantine Hcl | Memantine Hcl | 21 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Gemfibrozil | Gemfibrozil | 20 | suppressed |
| Glimepiride | Glimepiride | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Myrbetriq | Mirabegron | 20 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 19 | suppressed |
| Metronidazole | Metronidazole | 19 | 11 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 19 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 18 | suppressed |
| Insulin Lispro | Insulin Lispro | 18 | suppressed |
| Levetiracetam | Levetiracetam | 18 | suppressed |
| Mesalamine | Mesalamine | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | 16 |
| Rizatriptan | Rizatriptan Benzoate | 18 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 17 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 17 | suppressed |
| Humulin R U-500 Kwikpen | Insulin Regular, Human | 17 | suppressed |
| Temazepam | Temazepam | 17 | suppressed |
| Xarelto | Rivaroxaban | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 16 | suppressed |
| Cefdinir | Cefdinir | 15 | 13 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 14 | suppressed |
| Jantoven | Warfarin Sodium | 14 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 14 | suppressed |
| Nabumetone | Nabumetone | 14 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 14 | suppressed |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Armour Thyroid | Thyroid,pork | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Febuxostat | Febuxostat | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Dotti | Estradiol | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 12 | suppressed |
| Torsemide | Torsemide | 12 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Carisoprodol | Carisoprodol | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Metolazone | Metolazone | 11 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 11 | suppressed |
| Novolog | Insulin Aspart | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $121.21 · 6 records | VERTEX PHARMACEUTICALS INCORPORATED | ACTIV.A.C., Cologuard Collection Kit, JOURNAVX, PREVENA, REPATHA, XIFAXAN | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error